Variation curve of the extreme temperature index. by Chengyuan Hao (21615653)

“…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …”

Fluctuation trend of the mean temperature index. by Chengyuan Hao (21615653)

“…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …”

Variation curve of the mean temperature index. by Chengyuan Hao (21615653)

“…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …”

Overexpression of TNFAIP9 alleviated the renal fibrosis caused by 5/6 Nx in C57 mice. by Ying Chen (9697)

Overexpression of TNFAIP9 remitted the renal inflammation caused by 5/6 Nx in C57 mice. by Ying Chen (9697)

Overexpression of TNFAIP9 inhibited the TGF-β-induced fibrosis in HK-2 cells. by Ying Chen (9697)

Overexpression of TNFAIP9 suppressed inflammation in mouse peritoneal macrophages caused by 5/6 Nx in C57 mice. by Ying Chen (9697)

TNFAIP9 expression was increased in mice with chronic kidney disease (CKD) induced by 5/6 nephrectomy (Nx). by Ying Chen (9697)

Overexpression of TNFAIP9 counteracted the renal damage caused by 5/6 Nx in C57 mice. by Ying Chen (9697)

Overexpression of TNFAIP9 inhibited the TNF-α-induced inflammation in HK-2 cells. by Ying Chen (9697)

(a) Lactate suppression by sequential re-insertion of cmpd at low concentration in Jurkat cells. by Samo Lešnik (21073880)

Risk Illustration. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Predictors of SCD. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Clinical outcomes. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Obesity and Depressed Ejection Fraction. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Kaplan Meier curve. by Iftikhar Ali Ch (20783753)

“…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …”

Study data. by Jie Liu (15128)

“…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …”

Summary of clinical outcomes after 9 months. by Jie Liu (15128)

“…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …”

Approval by the research ethics committee. by Jie Liu (15128)

“…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …”

Dynamic characteristics of (A) FIB and (B) PCT between the survival and deceased groups of SFTS patients with HLH. by Bo Zhang (6559)